Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma.

Mehrazin R, Uzzo RG, Kutikov A, Ruth K, Tomaszewski JJ, Dulaimi E, Ginzburg S, Abbosh PH, Ito T, Corcoran AT, Chen DY, Smaldone MC, Al-Saleem T.

Urol Oncol. 2015 Sep;33(9):388.e19-25. doi: 10.1016/j.urolonc.2014.06.004. Epub 2014 Jul 11.

2.

Lymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma.

Saroha S, Uzzo RG, Plimack ER, Ruth K, Al-Saleem T.

J Urol. 2013 Feb;189(2):454-61. doi: 10.1016/j.juro.2012.09.166. Epub 2012 Oct 4.

3.

Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma.

Hutterer GC, Stoeckigt C, Stojakovic T, Jesche J, Eberhard K, Pummer K, Zigeuner R, Pichler M.

Urol Oncol. 2014 Oct;32(7):1041-8. doi: 10.1016/j.urolonc.2014.04.001. Epub 2014 Jul 11.

PMID:
25027686
4.

Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.

Kim KH, You D, Jeong IG, Kwon TW, Cho YM, Hong JH, Ahn H, Kim CS.

BJU Int. 2012 Dec;110(11 Pt B):E673-8. doi: 10.1111/j.1464-410X.2012.11498.x. Epub 2012 Sep 14.

5.

Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.

Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS.

Am J Surg Pathol. 1997 Jun;21(6):621-35.

PMID:
9199639
6.

Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V; Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.

BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.

7.

Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma.

Huang J, Feldman AS, Dong L, Cornejo K, Liu Q, Dahl DM, Wu S, Blute ML, Huang Y, Wu CL.

Clin Genitourin Cancer. 2015 Oct;13(5):e353-60. doi: 10.1016/j.clgc.2015.04.014. Epub 2015 May 4.

PMID:
25998556
8.

Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.

Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A.

J Urol. 2000 Apr;163(4):1090-5; quiz 1295.

PMID:
10737472
9.

Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.

Cornejo KM, Dong F, Zhou AG, Wu CL, Young RH, Braaten K, Sadow PM, Nielsen GP, Oliva E.

Hum Pathol. 2015 Oct;46(10):1411-7. doi: 10.1016/j.humpath.2015.07.001. Epub 2015 Jul 15.

PMID:
26297250
10.

Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.

Yamashita S, Ioritani N, Oikawa K, Aizawa M, Endoh M, Arai Y.

Int J Urol. 2007 Aug;14(8):679-83.

11.

Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinoma.

Hutterer GC, Pichler M, Chromecki TF, Strini KA, Klatte T, Pummer K, Remzi M, Mannweiler S, Zigeuner R.

Histopathology. 2013 Sep;63(3):309-15. doi: 10.1111/his.12163. Epub 2013 Jun 26.

PMID:
23802739
12.

Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery.

Ledezma RA, Negron E, Paner GP, Rjepaj C, Lascano D, Haseebuddin M, Dangle P, Shalhav AL, Crist H, Raman JD, Joel DeCastro G, Harik L, Paroder M, Uzzo RG, Kutikov A, Eggener SE.

World J Urol. 2016 May;34(5):687-93. doi: 10.1007/s00345-015-1692-3. Epub 2015 Sep 25.

PMID:
26407582
13.
14.

Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus.

Haddad AQ, Leibovich BC, Abel EJ, Luo JH, Krabbe LM, Thompson RH, Heckman JE, Merrill MM, Gayed BA, Sagalowsky AI, Boorjian SA, Wood CG, Margulis V.

Urol Oncol. 2015 Sep;33(9):388.e1-9. doi: 10.1016/j.urolonc.2015.04.010. Epub 2015 May 23.

PMID:
26004163
15.

Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database.

May M, Aziz A, Zigeuner R, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Hoschke B, Gilfrich C, Feciche B, Stoltze A, Fenske F, Fritsche HM, Figenshau RS, Madison K, Sánchez-Chapado M, Martin Mdel C, Salzano L, Lotrecchiano G, Joniau S, Waidelich R, Stief C, Brookman-May S; Members of the CORONA project the Young Academic Urologists Renal Cancer Group.

World J Urol. 2013 Oct;31(5):1073-80. doi: 10.1007/s00345-013-1071-x. Epub 2013 Apr 9.

PMID:
23568445
16.

The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma.

Rampersaud EN, Klatte T, Bass G, Patard JJ, Bensaleh K, Böhm M, Allhoff EP, Cindolo L, De La Taille A, Mejean A, Soulie M, Bellec L, Christophe Bernhard J, Pfister C, Colombel M, Belldegrun AS, Pantuck AJ, George D.

Urol Oncol. 2014 Jan;32(1):30.e9-13. doi: 10.1016/j.urolonc.2012.10.012. Epub 2013 Feb 17.

PMID:
23422777
17.

Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system.

Gettman MT, Blute ML, Spotts B, Bryant SC, Zincke H.

Cancer. 2001 Jan 15;91(2):354-61.

PMID:
11180082
18.

Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer.

Cho O, Oh YT, Chun M, Noh OK, Lee HW.

Tumour Biol. 2016 Jan;37(1):971-8. doi: 10.1007/s13277-015-3888-y. Epub 2015 Aug 12.

PMID:
26264618
19.

ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.

Kaffenberger SD, Morgan TM, Stratton KL, Boachie AM, Barocas DA, Chang SS, Cookson MS, Herrell SD, Smith JA, Clark PE.

BJU Int. 2012 Dec;110(11 Pt B):E641-6. doi: 10.1111/j.1464-410X.2012.11366.x. Epub 2012 Sep 7.

20.

Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.

Pan D, Xu L, Liu H, Zhang W, Zhu Y, Xu J, Gu J.

Jpn J Clin Oncol. 2015 Feb;45(2):202-9. doi: 10.1093/jjco/hyu194. Epub 2014 Nov 23.

PMID:
25420690

Supplemental Content

Support Center